New York 2025-2026 Regular Session

New York Assembly Bill A03845

Introduced
1/30/25  
Refer
1/30/25  

Caption

Establishes the psilocybin assisted therapy pilot program; provides such program will be offered to veterans and first responders from New York state; establishes a psilocybin assisted therapy pilot program fund.

Impact

If enacted, A03845 would create significant alterations in the state's public health law by integrating psilocybin as a recognized therapy option for mental health conditions among specific populations. The program relies on a newly established Psilocybin Assisted Therapy Pilot Program Fund, which is to be financed through state appropriations as well as potential grants. This funding will support operations and ensure therapeutic sessions can be conducted in a structured environment, which is expected to contribute positively to the mental health landscape for veterans and first responders facing psychological challenges.

Summary

Bill A03845 introduces a psilocybin-assisted therapy pilot program for veterans and first responders within New York State. The bill aims to establish a framework where certified practitioners can facilitate psilocybin therapy sessions aimed at treating conditions such as PTSD, depression, and anxiety. The proposal includes safeguards to ensure that participants are not subjected to legal repercussions for their involvement in the program, provided they adhere to state guidelines. The Department of Health will oversee the implementation and operation of this program, developing necessary rules and regulations for compliance.

Contention

Critics of A03845 may raise concerns regarding the potential stigma associated with using psilocybin, given its classification at the federal level, and the complexities surrounding its acceptance as a valid treatment method. Additionally, discussions around the ethical long-term implications of using psychedelics in therapeutic settings might fuel debates in the legislative forum. Proponents argue that the benefits of potentially effective treatment for mental health conditions far outweigh the negatives, as they seek legal pathways to relieve the suffering of those who have served their communities.

Companion Bills

NY S01801

Same As Establishes the psilocybin assisted therapy pilot program; provides such program will be offered to veterans and first responders from New York state; establishes a psilocybin assisted therapy pilot program fund.

Previously Filed As

NY S01801

Establishes the psilocybin assisted therapy pilot program; provides such program will be offered to veterans and first responders from New York state; establishes a psilocybin assisted therapy pilot program fund.

NY SF4485

Psilocybin therapeutic use program establishment

NY SF3971

Psilocybin therapeutic use program establishment

NY A1526

Establishes Psilocybin Behavioral Health Access and Therapy Pilot Program; appropriates $6 million.

NY H2203

Establishing a pilot program for access to regulated psilocybin

NY S00495

Relates to medical use of psilocybin; establishes a psilocybin assisted therapy grant program; makes an appropriation therefor.

NY A03775

Relates to medical use of psilocybin; establishes a psilocybin assisted therapy grant program; makes an appropriation therefor.

NY SB00191

An Act Concerning The Psychedelic-assisted Therapy Pilot Program.

NY H4986

Relative to therapeutic psilocybin treatment centers

NY A4204

Establishes pilot program in DOE to use therapy dogs in public elementary school wellness programs.

Similar Bills

NH HB1796

Allowing the use of psilocybin in approved clinical settings to treat qualified medical conditions.

IA HF978

A bill for an act relating to the production and administration of psilocybin, and providing penalties. (Formerly HF 620.)

IA HF620

A bill for an act relating to the production of psilocybin and the administration of psilocybin to persons with post-traumatic stress disorder, and providing penalties.(See HF 978.)

IA HF2085

A bill for an act relating to the production and administration of psilocybin and providing penalties.

NJ S3148

"Psilocybin Behavioral Health Access and Services Act"; authorizes production and use of psilocybin to promote health and wellness.

NH HB1809

Establishing a medical psilocybin advisory board to assess the advantages and disadvantages of the use of psilocybin for therapeutic purposes.

NM SB219

Medical Psilocybin Act

MA H4050

To amend the General Laws, in relation to promoting the health and well-being of the residents of the Commonwealth of Massachusetts by establishing a comprehensive framework supporting public health and safety through regulated adult use, support services, and cultivation of psilocybin-containing fungi; and providing for taxation and appropriation thereof